Genedrive receives second order from US Department of Defense
The company is targeting around 30 country registrations for the Genedrive HCV ID Kit by the end of June
Company
LON:GDR
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
240 stories · page 6 of 12
The company is targeting around 30 country registrations for the Genedrive HCV ID Kit by the end of June
Investments and investor services
FTSE 100 closed 40 points higher at 6,895, while the mid-cap FTSE 250 closed around 12 up at 18,429.
Archive
There will be some key data from the US and UK at the start of the new year, and Christmas retail trading news will be a dominant focus notably from Next PLC
Archive
There will be some key data from the US and UK at the start of the new year, and Christmas retail trading news will be a dominant focus notably from Next PLC
A look at some winners and losers in the UK equity market on Thursday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
genedrive thinks its simple out-reach test can help to cure hepatitis C in recovering heroin addicts, people who generally don’t like going to the doctors
Archive
The FTSE 250 index, though, fell around 30 points to 18,609 on the day
The company made positive operational progress in the year to June 30.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at the day's crackpots and jackpots, featuring Trakm8, Hutchison China Meditech, China Nonferrous, Empyrean, Good Energy Group, Falanx and Adept4
Hardware & electrical equipment
The proposed financing will "help the group drive towards demonstrable revenue growth and to advance the group's portfolio of additional tests, which if successful, are expected to increase shareholder value and enhance the strategic value
Investments and investor services
The UK's premier share index lost around 24 points at 7,013 on the day - and was down 1.29% on the week.
The launch at the Fertility Show in London at the start of November is the first step in a switch in focus brought about by new executive chairman Matthew Walls
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Under the agreement, FIND will lead evaluation studies between September 2018 and May 2019 to confirm the accuracy of Genedrive’s HCV kit across diverse genotypes
Investments and investor services
Sterling's fall was good news for the Footsie's many big dollar earners